secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001367644-25-000204
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions director Louis W. Sullivan to retire Nov 14 after 19 years
--------------------------------------------------------------------------------

- Dr. Sullivan notified board of retirement effective Nov 14, 2025; no disagreement with company.
- Served as director since 2006, most recently as Compensation Committee Chair and on Nominating/Governance.
- Former HHS Secretary and president of Morehouse School of Medicine.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000204/0001367644-25-000204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000204/ebs-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001367644-25-000204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer